Checking exon-skipping events in candidates for clinical trials of morpholino
Page 1 of 1
Checking exon-skipping events in candidates for clinical trials of morpholino
Jon Moulton Wed Feb 23, 2011 1:11 pm
Nakano S, Ozasa S, Yoshioka K, Fujii I, Mitsui K, Nomura K, Kosuge H, Endo F, Matsukura M, Kimura S. Checking exon-skipping events in candidates for clinical trials of morpholino. Pediatrics International. 2011 [Epub ahead of print] 10.1111/j.1442-200X.2011.03330.x
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Polyquaternium-mediated delivery of morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
» Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human Primates
» Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers
» Chemical and Mechanistic Toxicology Evaluation of Exon Skipping Phosphorodiamidate Morpholino Oligomers in mdx Mice
» A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)
» Toxicological Characterization of Exon Skipping Phosphorodiamidate Morpholino Oligomers (PMOs) in Non-human Primates
» Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers
» Chemical and Mechanistic Toxicology Evaluation of Exon Skipping Phosphorodiamidate Morpholino Oligomers in mdx Mice
» A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum